Quick Job Search
Keywords:
Company Name:
Job Type:
Location:
Job Seeker Tools
Latest Jobs
Job Seeker Tools
Your Saved Jobs
Build Your Professional Profile
Similar Jobs
WALGREENS
Customer Service Associate in Town of Mansfield, MA
IBM
Editorial Strategist in Cambridge, MA
Schneider Electric
Power System Engineer in Boston, MA
Cardinal Health
Sr. Specialist, Quality Assurance in Mansfield, MA
Textron
Parts and Service Admin - Boston Airport in Boston, MA
WALGREENS
Customer Service Associate - Temporary in New Bedford, MA
IBM
UX Designer in Cambridge, MA
Featured Employers
Global Market Access & Pricing Lead, COPD
Company: Sanofi
Location: Cambridge, MA
Employment Type: Full Time
Date Posted: 12/02/2021
Expire Date: 02/19/2022
Job Categories: Finance/Economics, Healthcare, Practitioner and Technician, Information Technology, Military, Franchising, Quality Control, Research & Development, Medical
Job Description
Global Market Access & Pricing Lead, COPD

JOB PURPOSE

The primary purpose of the role is to develop, update and support execution of the Global Market Access and Pricing (MAP) strategy, plans and tactics for Dupixent and Itepekimab COPD indications through best in class methodologies. The MAP COPD Lead is responsible for the optimization of the access and pricing opportunity across product’s lifecycle, with a focus on COPD indication but also considering the overall respiratory current and future portfolio. The MAP COPD Lead will work in close collaboration with the MAP respiratory team and the rest of the Dupixent MAP team, in line with the strategic brand ambition.

The Global Dupixent Market Access & Pricing COPD Lead ensures alignment with his/her team, HEVA Leads, GMAX CoE, Franchise Head and major markets to build successful access & pricing strategies and tools in order to realize the full pricing and access potential of Dupixent & Itepekimab.

This position provides a leadership role for alignment on Global Market Access and Pricing strategies and decisions within the GBU as well as & key role for GMAX community

KEY RESULTS/ACCOUNTABILITIES

  • Leads the development and supports execution of the access and pricing strategy for COPD indication for the 2 assets (Dupixent and itepekimab), in collaboration with the therapeutic global cross-functional partners (e.g. global project and brand teams, commercial, medical, regulatory, etc.) including input into clinical development plan and regulatory strategy

  • Supports development of respective TA market access perspective for key assets in scope leading to key committees: PFR, TARC, DWG, IDCC

  • Leads the Global Access and Pricing Policy and Guidance Development and updates in light of the lifecycle and launch of Dupixent and Itepekimab COPD indication (early stage, launch, line extension, updates according to competitive landscape evolution). Secures  approval from senior management and Regeneron (alliance products) and communicates updates and rationale internally

  • Closely collaborates with other Dupixent Market Access and Pricing members in respiratory & GI team as well as dermatology team and Market Access Liaison in order to ensure an overall franchise value optimization. As member of the TA Leadership team, contributes to the formulation and execution of the respiratory strategy and ensures key payer/ market access considerations are made explicit and addressed as appropriate

  • Leads the targeted payer value proposition definition for Dupixent & Itepekimab COPD indications in the context of the strategic brand planning & for the portfolio review in key markets, drawing on his/her payer network & research and leveraging collective Market Access & pricing team members, HEVA and GMAX CoE expertise.

  • Co-ordinates across functions (HEVA, MAP Lead) to support the definition of evidence needs for access for COPD indications, including epidemiology, patient outcomes, cost-effectiveness, budget impact and any other factor that may inform and guide global market access access/pricing and commercialization strategies.

    • In collaboration with HEVA head/leads, secure optimal integrated evidence generation plan (iEGP) in lights of payers requirements to enhance Payer Value proposition

  • Provides market access/pricing strategic inputs into product forecasts for Dupixent and Itepekimab COPD indication

  • Leads the pricing and access governance (internal and Alliance) for key markets, including strategy review and optimization, and coordination within the BU. He/She also reviews pricing & access recommendation proposed by the market liaison and CoE for Tiers 2 and 3 markets that planned to launch COPD

  • Nourish innovative contracting tools, developed together with the Global Pricing Center Of Excellence (CoE) team

  • Manages the timely development and secures approval of core Global Market Access deliverables that will support countries submissions and negotiations for COPD indications

    • Lead: Market Access & Pricing Strategy and Policy, Global Market Access blueprint, PVP, Payer Objection handler, Negotiation guide, Contracting guide, etc.

    • Support HEVA core deliverables: Core Value Dossier, Evidence Generation Plan, cost-effectiveness models, budget impact models, patient funnels, etc.

  • Ensures timely roll-out of payer deliverables for Dupixent & Itepekimab to all markets through identified Market Liaisons within her/his team. 

  • Manages the budget allocated to respiratory-related projects conducted by the MAP according to the Franchise/brand priorities and in close partnership with the GBU market access Head

  • Maintains a high level of knowledge with regards to the scientific, clinical, strategic pricing and commercial developments in the therapeutic area(s)

  • Develops and maintains a robust understanding of relevant pricing and reimbursement criteria used by payers in key markets to make informed decisions about payer strategy, plans and tactics.

SKILLS, EXPERIENCE & KNOWLEDGE REQUIREMENTS

  • >8-10 years experience in market access or pricing, with launch experience a plus

  • Advanced degree in analytics (e.g. MS) compulsory and additional qualification ( e.g MBA, MPhil, MD or PhD) preferred

  • Strong strategic and leadership skills as well as analytical skills to translate clinical information and messages into payer access strategies.

  • Demonstrated experience in scenario analyses (e.g., target patient population options, price/access trade- offs, co-payment sensitivity and portfolio  optimization modelling into price  and launch sequence  recommendations) related payer value proposition, evidence requirements, pricing and access potential for each scenario to shape disease area and commercial strategy as early as phase I or in-licensing to maximize commercial potential

  • Demonstrated ability to leverage research, scenario analyses and payer/pricing  insights to generate global integrated market access payer and pricing strategies and plans to maximize product differentiation most relevant to payers

  • Strong communications skills and the ability to work well in a cross-functional team

  • Deep understanding of strategic & operational Pricing

  • Understanding of payer value drivers within a specific disease area for portfolio management positioning, prioritization and trade-off decisions

  • Understanding of the evolution of the market access landscape and implications for the business

  • Knowledge of the success metrics of how the value proposition is delivered to key payers (i.e., what is required to command certain benefit ratings, P&R outcomes, reimbursement coding)

  • Track record of delivering payer relevant tools with positive measurable impact on the franchise/brand financials

  • Demonstrated ability to work effectively in close collaboration with cross-functional partners and across Market Access

  • Demonstrated ability to work across diverse and complex payer archetypes and priorities. Knowledge on health care system and reimbursement process in US, EU, Japan, China is welcome

  • Defined payer channel and role strategy, e.g., payer-facing capabilities you need to deliver into a specific channel

  • Created and raised awareness around the product value proposition 

  • Local and/or regional Market Access expertise experience is a plus

KEY WORKING RELATIONSHIPS - INTERNAL

Regular, close contact with:

  • Dupixent Global MAP team (across TA)

  • HEVA respiratory & GI head, HEVA COPD lead

  • Medical and Commercial COPD team

  • GBU MAx Head

  • Franchise Head & Business leads for key assets in scope

  • Global Project Heads & Leads

  • Major Local Market Access TA Heads, country Market Access Heads

  • Franchise Public Affairs

  • GBT members within Franchise

  • Pricing CoE Heads

EXTERNAL

Regular, close contact with:

  • HTA & payer related stakeholders at the market level

  • Alliance partners

Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

#GD-SA
#LI-SA

At Sanofi diversity and inclusion is foundational to how we operate and embedded in our Core Values. We recognize to truly tap into the richness diversity brings we must lead with inclusion and have a workplace where those differences can thrive and be leveraged to empower the lives of our colleagues, patients and customers. We respect and celebrate the diversity of our people, their backgrounds and experiences and provide equal opportunity for all.

Contact Information
Apply Now | Forward Job to a Friend | More Jobs From This Employer